- $1.08bn
- $1.58bn
- $388.79m
- 73
- 61
- 77
- 81
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 280 | 892 | 878 | 439 | 389 |
Cost of Revenue | |||||
Gross Profit | 272 | 814 | 751 | — | — |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 349 | 723 | 872 | 286 | 253 |
Operating Profit | -68.7 | 169 | 5.8 | 153 | 136 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -83.1 | 136 | -30.5 | 110 | 80 |
Provision for Income Taxes | |||||
Net Income After Taxes | -67 | 142 | -55.9 | 139 | 67.4 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -62.5 | 147 | -55.5 | -296 | 67.4 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -62.5 | 147 | -55.5 | -296 | 67.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.27 | 1.95 | -0.379 | 3.62 | 0.706 |
Dividends per Share |